Reuma.pt course – from theory to practice

Platform for projects submission

26000 patients

Tickets

Access to the patient's area

Automated informed consent

13 years of Reuma.pt

COVID-19 vaccination

Season’s Greetings

Acknowledgment

COVID-19 patients at Reuma.pt

End of mandate, accounting period

24000 patients

Online questionnaires for patients & Biosimilar drugs

Musculoskeletal ultrasound

39 COVID-19 patients at Reuma.pt

COVID-19 patients at Reuma.pt

We stay at home, but connected and working

12 years of Reuma.pt

Total at the end of 2019

Season’s Greetings

PRO Rheuma initiative

22000 patients

Biosimilar drugs

Follow-up Losses

Projects and Publications

21000 patients

Informed (Re)Consent

New Protocol MYOSITIS

Osteoarthritis protocol

11 years of Reuma.pt

Total at the end of 2018

20000 patients

Rheumatoid arthritis protocol

Drugs and adverse events

Access to the patient's area

Scleroderma

Prescription and dispensing of biological drugs

19000 patients

General Data Protection Regulation

End of mandate, accounting period

Biosimilar drugs

10 years of Reuma.pt

Total at the end of 2017

Use of Reuma.pt by patients

18000 patients

Vasculitis

Adverse events associated with biologic drugs

Dates of diagnosis and disease onset

Loss to follow-up

RAID

Geographical distribution of Reuma.pt patients

Early arthritis

Biological drugs

9 years of Reuma.pt

Total at the end of 2016

Clinical trials: Biomarkers in ankylosing spondylitis

1ª Edition of Janssen Innovation Award

End of mandate, accounting period

Patients adherence to Reuma.pt

Data extraction

Sjögren´s syndrome

15000 patients

Hepatitis B and C serology tests

Patient's self assessment forms

Biological drugs

Biosimilar drugs

Security of the biological therapies

Total at the end of 2015

Scientific articles

100 000 visits

Scleroderma

Active TB disease

Clinical trial for patients with gonarthrosis

Lab analysis

Pediatric rheumatology

Frequently Asked Questions

Clinical trials: GO-DACT

Osteoarthritis

Biological treatments

Total at the end of 2014

Visits at the start of biological treatments

Vasculitis

End of mandate, accounting period

Apps on the Reuma.pt website

Selection of patients through filters

Analysis of data inconsistencies

Reuma.pt outputs

Adverse drug reactions

Sharing patients between centres

6 years of Reuma.pt

Autoinflammatory syndromes

10.000 patients and 60.000 visits

"Hospital do Futuro 2012/2013" Awards

Patient's self assessment forms

Statistical reports, a new tool at your disposal in Reuma.pt

The Reuma.pt is already over 6000 patients, having grown 50% in just over a year. The number of registered visits is about 38.000

Inconsistencies report, a new tool available to increase data quality

Reuma.pt web version - available from April 16

The Reuma.pt has as total of 4749 patients, 1500 treated with biological agents!

It is essential to fill in DAS28 components at every visit of patients with RA

The Reuma.pt grew 25% in last half year, having now almost 4000 patients!!

It is essential to introduce the data for the visit before the beginning of treatment with biological agent

It is essential to enter data currently missing in Reuma.pt!

The Reuma.pt already includes more than 15000 visits, > 4 visits / patient on average!

The Reuma.pt already surpassed the threshold of 3000 patients!!